http://www.emednews.org/2006/12/26/msf-asks-novartis-to-drop-challenge-to-indian-patent-system/ Global updates on access to essential medicines Mon, 06 Sep 2010 14:59:49 +0000 http://wordpress.org/?v=2.1.2 http://www.emednews.org/2006/12/26/msf-asks-novartis-to-drop-challenge-to-indian-patent-system/#comment-7 Lancet editorial: “grave implications” for Novartis India suit, U.S. Thai inference at Essential Medicines News Sat, 06 Jan 2007 20:57:17 +0000 http://www.emednews.org/2006/12/26/msf-asks-novartis-to-drop-challenge-to-indian-patent-system/#comment-7 [...] The editorial discusses Novartis’ suit against the Indian government, challenging Indian patent law, and the U.S. pressure on Thailand not to grant a compulsory license for the AIDS drug efavirenz. Two international campaigns are currently defending the legal rights of the world’s poorest people to access the essential medicines they need. Both campaigns are calling for the rules of Trade Related Aspects of Intellectual Property (TRIPS), a binding World Trade Organisation agreement, to be upheld and are targeting the pharmaceutical industry and the US Government. … [...] […] The editorial discusses Novartis’ suit against the Indian government, challenging Indian patent law, and the U.S. pressure on Thailand not to grant a compulsory license for the AIDS drug efavirenz. Two international campaigns are currently defending the legal rights of the world’s poorest people to access the essential medicines they need. Both campaigns are calling for the rules of Trade Related Aspects of Intellectual Property (TRIPS), a binding World Trade Organisation agreement, to be upheld and are targeting the pharmaceutical industry and the US Government. … […]

]]>